DK1364030T3 - Supersecernerbare peptider, processer til frembringelse herf og parallel forbedring af den secernerede form at et eller flere andre polypeptider - Google Patents

Supersecernerbare peptider, processer til frembringelse herf og parallel forbedring af den secernerede form at et eller flere andre polypeptider

Info

Publication number
DK1364030T3
DK1364030T3 DK02716745T DK02716745T DK1364030T3 DK 1364030 T3 DK1364030 T3 DK 1364030T3 DK 02716745 T DK02716745 T DK 02716745T DK 02716745 T DK02716745 T DK 02716745T DK 1364030 T3 DK1364030 T3 DK 1364030T3
Authority
DK
Denmark
Prior art keywords
protein
dna sequence
codon
lys
arg
Prior art date
Application number
DK02716745T
Other languages
English (en)
Inventor
Paul Habermann
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1364030T3 publication Critical patent/DK1364030T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
DK02716745T 2001-02-20 2002-02-08 Supersecernerbare peptider, processer til frembringelse herf og parallel forbedring af den secernerede form at et eller flere andre polypeptider DK1364030T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10108100A DE10108100A1 (de) 2001-02-20 2001-02-20 Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse

Publications (1)

Publication Number Publication Date
DK1364030T3 true DK1364030T3 (da) 2006-07-17

Family

ID=7674831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02716745T DK1364030T3 (da) 2001-02-20 2002-02-08 Supersecernerbare peptider, processer til frembringelse herf og parallel forbedring af den secernerede form at et eller flere andre polypeptider

Country Status (21)

Country Link
EP (1) EP1364030B1 (da)
JP (1) JP4243103B2 (da)
KR (1) KR100858008B1 (da)
CN (1) CN100575493C (da)
AT (1) ATE320498T1 (da)
AU (1) AU2002247696B2 (da)
BR (1) BR0207385A (da)
CA (1) CA2438935C (da)
CY (1) CY1105696T1 (da)
DE (2) DE10108100A1 (da)
DK (1) DK1364030T3 (da)
ES (1) ES2258619T3 (da)
HK (1) HK1065818A1 (da)
IL (1) IL157415A0 (da)
MX (1) MXPA03007115A (da)
NO (1) NO331375B1 (da)
NZ (1) NZ527641A (da)
PE (1) PE20020875A1 (da)
PT (1) PT1364030E (da)
WO (1) WO2002066628A2 (da)
ZA (1) ZA200305867B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060233808A1 (en) * 2003-04-04 2006-10-19 David Deperthes Peptabody for cancer treatment
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
PT2349324T (pt) 2008-10-17 2017-12-06 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
PL2498802T3 (pl) 2009-11-13 2015-06-30 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
EP2498801B1 (de) 2009-11-13 2018-01-24 Sanofi-Aventis Deutschland GmbH HARMAZEUTISCHE ZUSAMMENSETZUNG UMFASSEND desPro36Exendin-4(1-39)-Lys6-NH2 UND METHIONIN
EP2611458B1 (en) 2010-08-30 2016-09-21 Sanofi-Aventis Deutschland GmbH Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
BR112014004726A2 (pt) 2011-08-29 2017-04-04 Sanofi Aventis Deutschland combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN108866205A (zh) * 2018-07-25 2018-11-23 中国食品药品检定研究院 基于分子生物学方法鉴别菲牛蛭的特异性引物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58906966D1 (de) * 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
FI92601C (fi) 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista

Also Published As

Publication number Publication date
PE20020875A1 (es) 2002-10-31
NO331375B1 (no) 2011-12-12
ATE320498T1 (de) 2006-04-15
BR0207385A (pt) 2004-02-10
IL157415A0 (en) 2004-03-28
DE60209883T2 (de) 2006-09-07
WO2002066628A2 (en) 2002-08-29
MXPA03007115A (es) 2003-11-18
KR20030074832A (ko) 2003-09-19
CY1105696T1 (el) 2010-12-22
EP1364030A2 (en) 2003-11-26
EP1364030B1 (en) 2006-03-15
AU2002247696B2 (en) 2006-10-12
CN1527882A (zh) 2004-09-08
CN100575493C (zh) 2009-12-30
DE60209883D1 (de) 2006-05-11
HK1065818A1 (en) 2005-03-04
PT1364030E (pt) 2006-05-31
JP2004518442A (ja) 2004-06-24
WO2002066628A3 (en) 2002-11-14
ZA200305867B (en) 2004-06-29
NZ527641A (en) 2005-03-24
NO20033671L (no) 2003-10-17
DE10108100A1 (de) 2002-08-29
JP4243103B2 (ja) 2009-03-25
KR100858008B1 (ko) 2008-09-11
CA2438935C (en) 2012-01-24
ES2258619T3 (es) 2006-09-01
CA2438935A1 (en) 2002-08-29
NO20033671D0 (no) 2003-08-19

Similar Documents

Publication Publication Date Title
CY1105696T1 (el) Υπερεκκρινομενα πεπτιδια, διεργασιες για την παραγωγη τους και παραλληλη βελτιωση του εκκρινομενου ειδους ενος ή περισσοτερων αλλων πεπτιδιων
CY1106274T1 (el) Χρηση πρωτεϊνων συντηξης των οποιων το ν-τελικο τμημα ειναι ενα παραγωγο ιρουδινης για την παραγωγη ανασυνδυασμενων πρωτεϊνων μεσω εκκρισης απο ζυμομυκητα
EP0651761B1 (en) Method for modification of recombinant polypeptides
NO965411L (no) N-terminalt forlengede proteiner uttrykt i gjær
ATE421977T1 (de) Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie
George-Nascimento et al. Characterization of recombinant human epidermal growth factor produced in yeast
DK1819816T3 (da) Fremgangsmåder til fremstilling og udskillelse af modificerede peptider
Katsoyannis The synthesis of the insulin chains and their combination to biologically active material
NO930428L (no) Proteinstrukturen til plantetoksingelonin
ATE253639T1 (de) Verfahren zur herstellung von peptiden
DK1179593T3 (da) Fremgangsmåde til fremstilling af rekombinant insulin fra nyt fusionsprotein
US5656456A (en) Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof
DK0408764T3 (da) Fremgangsmåde til fremstilling af alfa-amiderede peptider
EP1532262A2 (en) Petide amidation process
ES2316588T3 (es) Metodo para hacer polipeptidos acilados.
JP2012531199A (ja) 生物的に生成される環状アフィニティータグ
ES2074087T3 (es) Peptido-señal y secuencias de adn que codifican para el mismo.
JPS63254994A (ja) N置換ロイシンエンケフアリンアミドの製造方法
McKinney Studies of the Saccharomyces cerevisiae alpha-factor mating pheromone and its receptor (the STE2 gene product)
JPH06169790A (ja) 酵素を用いるペプチド合成方法